# Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center – FDA Inspection, Jun 26, 2015

Source: https://www.keypedia.com/records/fda_inspections/rhode-island-blood-center-a-division-of-new-york-blood-center-inc-westerly-donor-center/a97aafbd-6d06-43b0-b30f-5df66e755feb
Source feed: FDA_Inspections

> FDA inspection 935613 of Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center, June 26, 2015. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 606. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 935613
- Company Name: Rhode Island Blood Center, a Division of New York Blood Center, Inc., Westerly Donor Center
- Inspection Date: 2015-06-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 3

## Related Documents

- FDA Inspection 1167109 - 2022-04-15
- FDA Inspection 1084698 - 2019-03-08
- [FDA Inspection 1021052 - 2017-08-10](https://www.keypedia.com/records/fda_inspections/rhode-island-blood-center-a-division-of-new-york-blood-center-inc-westerly-donor-center/9496e7b1-8bc0-4aba-ae7a-7ed40ef8087c)
- FDA Inspection 846018 - 2013-07-29

Company: https://www.keypedia.com/companies/rhode-island-blood-center-a-division-of-new-york-blood-center-inc-westerly-donor-center/eb7be4e4-3bcf-4d2e-aa3c-c8de08b75a1a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
